Metropolitan Life Insurance Company (MetLife)’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-68,923
| Closed | -$3.19M | – | 2683 |
|
|
2019
Q2 | $3.19M | Buy |
68,923
+1,101
| +2% | +$51K | 0.05% | 313 |
|
|
2019
Q1 | $1.65M | Sell |
67,822
-634
| -0.9% | -$15.5K | 0.03% | 588 |
|
|
2018
Q4 | $975K | Buy |
68,456
+684
| +1% | +$9.75K | 0.02% | 823 |
|
|
2018
Q3 | $1.03M | Hold |
67,772
| – | – | 0.02% | 920 |
|
|
2018
Q2 | $1.14M | Sell |
67,772
-60,464
| -47% | -$1.01M | 0.02% | 854 |
|
|
2018
Q1 | $2.09M | Buy |
128,236
+65,618
| +105% | +$1.07M | 0.03% | 512 |
|
|
2017
Q4 | $802K | Sell |
62,618
-56,067
| -47% | -$718K | 0.01% | 1015 |
|
|
2017
Q3 | $1.46M | Sell |
118,685
-491
| -0.4% | -$6.04K | 0.01% | 1056 |
|
|
2017
Q2 | $998K | Buy |
119,176
+1,021
| +0.9% | +$8.55K | 0.01% | 1250 |
|
|
2017
Q1 | $1.06M | Buy |
118,155
+404
| +0.3% | +$3.61K | 0.01% | 1203 |
|
|
2016
Q4 | $1.04M | Buy |
117,751
+19,033
| +19% | +$167K | 0.01% | 1278 |
|
|
2016
Q3 | $666K | Buy |
98,718
+531
| +0.5% | +$3.58K | ﹤0.01% | 1530 |
|
|
2016
Q2 | $350K | Hold |
98,187
| – | – | ﹤0.01% | 1917 |
|
|
2016
Q1 | $290K | Buy |
98,187
+927
| +1% | +$2.74K | ﹤0.01% | 1926 |
|
|
2015
Q4 | $410K | Hold |
97,260
| – | – | ﹤0.01% | 1751 |
|
|
2015
Q3 | $444K | Buy |
97,260
+4,538
| +5% | +$20.7K | ﹤0.01% | 1719 |
|
|
2015
Q2 | $669K | Sell |
92,722
-11,475
| -11% | -$82.8K | ﹤0.01% | 1555 |
|
|
2015
Q1 | $768K | Buy |
104,197
+3,806
| +4% | +$28.1K | 0.01% | 1352 |
|
|
2014
Q4 | $475K | Hold |
100,391
| – | – | ﹤0.01% | 1794 |
|
|
2014
Q3 | $358K | Buy |
100,391
+22,968
| +30% | +$81.9K | ﹤0.01% | 1950 |
|
|
2014
Q2 | $353K | Sell |
77,423
-21,829
| -22% | -$99.5K | ﹤0.01% | 2076 |
|
|
2014
Q1 | $466K | Hold |
99,252
| – | – | ﹤0.01% | 1859 |
|
|
2013
Q4 | $497K | Hold |
99,252
| – | – | ﹤0.01% | 1819 |
|
|
2013
Q3 | $617K | Buy |
99,252
+1,521
| +2% | +$9.46K | ﹤0.01% | 1610 |
|
|
2013
Q2 | $444K | Buy |
+97,731
| New | +$444K | ﹤0.01% | 1770 |
|